SCHEMBL8092536

SCHEMBL8092536

N#Cc1cc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(F)cc2)nc1NCc1ccccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.43
PTGS1 P23219 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
LMNA P02545 4/20 0.39
HTT P42858 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
IKBKB O14920 1/20 0.38
CHUK O15111 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8101829 0.91 PTGS2 (0.52) PTGS2PTGS1
SCHEMBL8093987 0.85 PTGS2 (0.48) PTGS2PTGS1CA1CA2CA12
SCHEMBL8094187 0.84 CNR1 (0.50) PTGS2CA1CA2CA12CA9
SCHEMBL8086615 0.84 PTGS2 (0.49) PTGS2PTGS1CA1CA2CA12
SCHEMBL8094849 0.83 HPGD (0.48) PTGS2PTGS1CA1CA2CA12
SCHEMBL8085724 0.83 PTGS2 (0.51) PTGS2PTGS1CA1CA2CA12
SCHEMBL8086911 0.82 HPGD (0.45) PTGS2PTGS1CA1CA2CA12
SCHEMBL8093864 0.82 CA9 (0.44) PTGS2PTGS1CA1CA2CA12
SCHEMBL8099660 0.81 MAPT (0.49) PTGS2PTGS1CA1CA2CA9
SCHEMBL8419642 0.80 ACLY (0.40) PTGS2SMN1; SMN2LMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed